Learn About Enrollment in a Clinical Trial Sponsored by Conformal
The Conformal Early Feasibility Study is an evaluation of the safety and performance of the Conformal LAAC implant. This is a prospective, multicenter, open-label, first-in-human study.
The study will enroll up to 45 adults aged 18 or older with documented non-valvular atrial fibrillation and high risk of stroke or systemic embolism, who have been advised to take oral anticoagulation therapy, but have appropriate reasons to seek a non-pharmacologic alternative.
There are other criteria for participation in this study. For more information, visit clinicaltrials.gov.